Optimal timing for initiating first-line palliative systemic therapy in asymptomatic metastatic esophagogastric cancer: Insights from a European Delphi study
European Journal of Cancer · 2025
DOI: 10.1016/j.ejca.2025.115278 ↗Kurz gefasst
Delphi-Studie in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Denice Kamp und 19 weiteren Autor:innen. Beteiligte Einrichtung: Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Palliative Care, Stomach Neoplasms, Esophageal Neoplasms, Time-to-Treatment. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vrienden UMC Utrecht.
Abstract (Originalsprache)
BACKGROUND: The enhanced application of imaging techniques is resulting in the diagnosis of more patients with asymptomatic metastatic esophagogastric cancer (mEGC). We conducted a Delphi study to gather insights from European experts on the optimal timing for initiating palliative systemic therapy for these patients. METHODS: An online survey featured 14 scenarios where physicians chose their preferred timing for initiating systemic therapy: immediate(
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
- Medical Oncology department, Institut du Cancer de Montpellier, Montpellier, France.
- Department of Medical Oncology, Unidade Local de Saúde de Gaia e Espinho, Villa Nova de Gaia, Portugal.
- Department of Medical Oncology, Amsterdam UMC, Free University, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, the Netherlands.
- Department of Radiological, Oncological and Pathological Sciences, "Sapienza" University of Rome, Policlinico Umberto I, Rome, Italy.
- Department of Oncology, University Medical Centre Maribor, Maribor, Slovenia.
Förderung
- Vrienden UMC Utrecht
Zitieren
APA
Kamp, D., May, A. M., Adenis, A., Capela, A., Derks, S., De Felice, F., Dovnik, N. F., Hierro, C., Ilhan-Mutlu, A., Lordick, F., Obermannova, R. L., Petrillo, A., Puccini, A., Raimundo, A., Roviello, G., Siebenhüner, A., Slingerland, M., Smyth, E. C., van Laarhoven, H. W. M., & Mohammad, N. H. (2025). Optimal timing for initiating first-line palliative systemic therapy in asymptomatic metastatic esophagogastric cancer: Insights from a European Delphi study. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115278
Vancouver
Kamp D, May AM, Adenis A, Capela A, Derks S, De Felice F, et al. Optimal timing for initiating first-line palliative systemic therapy in asymptomatic metastatic esophagogastric cancer: Insights from a European Delphi study. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.115278
BibTeX
@article{Kamp2025,
author = {Kamp, Denice and May, Anne M and Adenis, Antoine and Capela, Andreia and Derks, Sarah and De Felice, Francesca and Dovnik, Nina Fokter and Hierro, Cinta and Ilhan-Mutlu, Aysegul and Lordick, Florian and Obermannova, Radka Lordick and Petrillo, Angelica and Puccini, Alberto and Raimundo, Ana and Roviello, Giandomenico and Siebenhüner, Alexander and Slingerland, Marije and Smyth, Elizabeth C and van Laarhoven, Hanneke W M and Mohammad, Nadia Haj},
title = {Optimal timing for initiating first-line palliative systemic therapy in asymptomatic metastatic esophagogastric cancer: Insights from a European Delphi study},
journal = {European Journal of Cancer},
year = {2025},
doi = {10.1016/j.ejca.2025.115278}
}
EUVIMED